Overexpression of PTGS2, which occurs frequently in premalignant and malignant neoplasms, including hematological malignancies (Bernard et al. 2008), together with overexpression of the prostaglandin cascade, leads to carcinogenesis through a progressive series of highly specific cellular and molecular changes (Harris 2009). This evidence concerns the gene PTGS2 and cancer.